Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil;Rezidivierendes reversibles posteriores leukenzephalopathiesyndrom unter chemotherapie mit cisplatin und 5-fluorouracil

Nervenarzt

Volumn 77, Issue 6, 2006, Pages 706-710

  Paul, F ^a   Aktas, O ^a   Dieste, F J ^b   Kreitsch, P ^b   Vogel, H P ^b   Zipp, F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HELIOS Klinikum Berlin   (Germany)

Author keywords

5 Fluorouracil; Cisplatin; Gastric cancer; Posterior leukoencephalopathy; Tonic clonic seizures

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BRAIN ISCHEMIA; CANCER CHEMOTHERAPY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; HUMAN; LEUKOENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CEREBRAL ARTERY; RECURRENT DISEASE; REMISSION; STOMACH CANCER; TONIC CLONIC SEIZURE; CHEMICALLY INDUCED DISORDER; DRUG THERAPY; MALE; SEIZURE; STOMACH TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DRUG THERAPY; FLUOROURACIL; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; RECURRENCE; SEIZURES; STOMACH NEOPLASMS;

EID: 33746431410     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-006-2055-5     Document Type: Article

References (17)

1. Ay H, Buonanno FS, Schaefer PW et al. (1998) Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 51:1369-1376
2. Beausang-Linder M, Bill A (1981) Cerebral circulation in acute arterial hypertension-protective effects of sympathetic nervous activity. Acta Physiol Scand 111:193-199
3. Casey SO, Sampaio RC, Michel E et al. (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199-1206
4. Dietrich J, Marienhagen J, Schalke B et al. (2004) Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide. Ann Pharmacother 38:242-246
5. Hinchey J, Chaves C, Appignani B et al. (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494-500
6. Ito Y, Arahata Y, Goto Y et al. (1998) Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 19:415-417
7. Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725-1738
8. Lamy C, Oppenheim C, Meder JF et al. (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14:89-96
9. Meglic B, Graus F, Grad A (2001) Anti-Yo-associated paraneoplasticcerebellar degeneration in a man with gastric adenocarcinoma. J Neural Sci 185:135-138
10. Neef C, de Voogd-van der Straaten I (1988) An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther 43:372-375
11. Steeghs N, de Jongh FE, Sillevis Smitt PAE et al. (2003) Cisplatin-induced encephalopathy and seizures. Anticancer Drugs 14:443-446
12. Sueblinvong T, Noophun P, Pataradool K et al. (2002) Posterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary. J Obstet Gynaecol Res 28:99-103
13. Sutton IJ, Fursdon Davis CJ, Esiri MM et al. (2001) Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol 49:253-257
14. Verstappen CC, Heimans JJ, Hoekman K et al. (2003) Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63:1549-1563
15. Voltz R (2002) Paraneoplastische neurologische Autoimmunerkrankungen. Nervenarzt 73:909-929
16. Weidauer S, Krakow K, Lanfermann H et al. (2001) Reversible bilaterale kortikale MRT-Veränderungen infolge einer Anfallsserie. Nervenarzt 72:958-962
17. Weller M (2003) Neuroonkologie. Nervenarzt 74:1139-1149